Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of amonafide dosing based on acetylator phenotype.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of amonafide dosing based on acetylator phenotype.
Phase I study of amonafide dosing based on acetylator phenotype. Cancer Res. 1993 May 15; 53(10 Suppl):2304-8.
View in:
PubMed
subject areas
Acetylation
Adenine
Adult
Aged
Antineoplastic Agents
Dose-Response Relationship, Drug
Female
Humans
Imides
Intercalating Agents
Isoquinolines
Lymphoma
Male
Middle Aged
Models, Biological
Naphthalimides
Neoplasms
Organophosphonates
Phenotype
authors with profiles
Richard Schilsky
Mark J. Ratain